Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Silence Therapeutics (SLN) Return on Assets: 2025

Historic Return on Assets for Silence Therapeutics (SLN) over the last 2 years, with Sep 2025 value amounting to 0.10%.

  • Silence Therapeutics' Return on Assets was N/A to 0.10% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.10%, marking a year-over-year change of. This contributed to the annual value of 0.28% for FY2024, which is N/A change from last year.
  • As of Q3 2025, Silence Therapeutics' Return on Assets stood at 0.10%, which was up 38.74% from 0.17% recorded in Q2 2025.
  • Over the past 5 years, Silence Therapeutics' Return on Assets peaked at 0.10% during Q3 2025, and registered a low of 0.44% during Q1 2024.